We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Synthetic Biologists Create Interlinked Microbial Populations

By LabMedica International staff writers
Posted on 09 Sep 2015
A team of synthetic biologists has demonstrated a method for controlling how populations of microbial cells interact and regulate each other.

A challenge of synthetic biology is the creation of cooperative microbial systems that exhibit population-level behaviors. More...
Such systems use cellular signaling mechanisms to regulate gene expression across multiple cell types.

In an attempt to create such a system artificially, investigators at Rice University (Houston, TX, USA) constructed a synthetic microbial consortium from genetically engineered populations of E. coli that comprised two distinct cell types—an “activator” strain and a “repressor” strain. The activator strain upregulated the expression of targeted genes while the repressor strain downregulated the same genes. The bacteria, which were grown in microfluidic culture devices, had been engineered to synthesize fluorescent reporter genes so their activities could be monitored.

Results published in the August 28, 2015, issue of the journal Science revealed that the strains produced two orthogonal cell-signaling molecules that regulated gene expression within a synthetic circuit spanning both strains. Of particular interest was the observation that the two strains generated emergent, population-level oscillations only when cultured together.

"The main push in synthetic biology has been to engineer single cells," said senior author Dr. Matthew R. Bennett, assistant professor of biochemistry and cell biology at Rice University. "But now we are moving toward multicellular systems. We want cells to coordinate their behaviors in order to elicit a populational response, just the way our bodies do. We have many different types of cells in our bodies, from skin cells to liver cells to pancreatic cells, and they all coordinate their behaviors to make us work properly. To do this, they often send out small signaling molecules that are produced in one cell type and effect change in another cell type. We take that principle and engineer it into these very simple organisms to see if we can understand and build multicellular systems from the ground up."

Related Links:

Rice University



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
All-in-One Molecular System
AIO M160
New
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical abstract (Pola, I., Akinyemi, T., Tan, K. et al. Nature Communications(2026). https://doi.org/10.1038/s41467-026-74971-4)

Blood Biomarker Study Reveals Population-Specific Differences in Alzheimer’s Disease

Blood-based biomarkers are emerging as tools for detecting Alzheimer’s disease–related changes without relying on advanced brain imaging or cerebrospinal fluid (CSF) analysis. However, much of the foundational... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.